A writer explores his father's mysterious imprisonment, and accusations that he was spying for the CIA, in revolutionary-era Iran.
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
- Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
Most Recent Shows
A lame duck, with diminished power to get anything done: This is how many had expected to describe President Barack Obama in his final two years in office. But Obama has had a string of recent victories, and now, he’s setting his sights on other issues. We look at the president's evolution and his political priorities for the remainder of his term.
Turkish jets attack Islamic State positions in Syria for the first time. Negotiations begin in Athens on a third bailout for Greece. And President Barack Obama visits Kenya and Ethiopia. A panel of journalists joins guest host Susan Page of USA Today for analysis of the week's top international news stories.
Secretary of State John Kerry defends the Iran nuclear deal in Congress. Republican candidates scramble for a spot in the upcoming GOP debate. And a dash-cam video of Sandra Bland’s arrest in Texas fuels debate over her death. A panel of journalists joins guest host Susan Page for analysis of the week's top national news stories.